258 related articles for article (PubMed ID: 4198306)
1. Clorazepate dipotassium, diazepam and placebo in chronic anxiety.
Feurst SI
Curr Ther Res Clin Exp; 1973 Jul; 15(7):449-59. PubMed ID: 4198306
[No Abstract] [Full Text] [Related]
2. Clorazepate dipotassium in anxiety: a double-blind trial with diazepam controls.
Wiersum J
Curr Ther Res Clin Exp; 1972 Aug; 14(8):442-8. PubMed ID: 4629306
[No Abstract] [Full Text] [Related]
3. Controlled trial of dipotassium clorazepate ("Tranxene") in anxiety.
Cooper AJ; Magnus RV; Rose M; Phanjoo A; Lancaster NP; Pollard P; Knowlson P
Br J Psychiatry; 1973 Oct; 123(575):475-6. PubMed ID: 4584032
[No Abstract] [Full Text] [Related]
4. A multicenter investigation of lorazepam in anxiety neurosis.
Nanivadekar AS; Wig NN; Khorana AB; Master RS; Kulkarni SS
Curr Ther Res Clin Exp; 1973 Jul; 15(7):500-7. PubMed ID: 4198313
[No Abstract] [Full Text] [Related]
5. Chlorazepate dipotassium in the treatment of anxiety associated with chronic gastrointestinal disease.
Kasich AM
Curr Ther Res Clin Exp; 1973 Mar; 15(3):83-91. PubMed ID: 4196231
[No Abstract] [Full Text] [Related]
6. Once-a-day potassium clorazepate in anxiety.
Magnus RV
Br J Clin Pract; 1973 Dec; 27(12):449-52. PubMed ID: 4590788
[No Abstract] [Full Text] [Related]
7. [Comparative study of the anxiolytic efficacy of lorazepam (WY 4036) and diazepam (Valium)].
De Buck R; Boon H; Pelc I
Acta Psychiatr Belg; 1972 Mar; 72(2):185-98. PubMed ID: 4560256
[No Abstract] [Full Text] [Related]
8. Clorazepate (tranxene). Another benzodiazepine.
Med Lett Drugs Ther; 1972 Nov; 14(23):85-6. PubMed ID: 4630756
[No Abstract] [Full Text] [Related]
9. Clorazepate dipotassium in anxiety: a clinical trial with diazepam and placebo controls.
Ricca JJ
J Clin Pharmacol New Drugs; 1972 Jul; 12(7):286-90. PubMed ID: 4557537
[No Abstract] [Full Text] [Related]
10. Clinical trial of dipotassium chlorazepate, a new benzodiazepine derivative.
Juhlin L; Opitz B
Nord Psykiatr Tidsskr; 1973; 27(1):35-9. PubMed ID: 4569218
[No Abstract] [Full Text] [Related]
11. A comparison of lorazepam, diazepam and placebo in the treatment of anxiety states.
Singh AN; Saxena B
Curr Ther Res Clin Exp; 1974 Mar; 16(3):149-62. PubMed ID: 4206723
[No Abstract] [Full Text] [Related]
12. Clinical and physiological assessment of chlorazepate, diazepam and placebo in anxious neurotics.
Lapierre YD
Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):315-22. PubMed ID: 239907
[TBL] [Abstract][Full Text] [Related]
13. Clinical and computerized EEG effects of U-31,920, a new anxiolytic.
Itil TM; Akpinar S; Ozkut H; Balki N; Herrmann WM
Curr Ther Res Clin Exp; 1974 Jun; 16(6):642-54. PubMed ID: 4211146
[No Abstract] [Full Text] [Related]
14. Comparison of prazepam and placebo in the treatment of convalescing narcotic addicts.
Sugerman AA; Miksztal MW; Freymuth HW
J Clin Pharmacol New Drugs; 1971; 11(5):383-7. PubMed ID: 4935717
[No Abstract] [Full Text] [Related]
15. SCH-12,041, a new anti-anxiety agent (quantitative pharmaco-electroencephalography and clinical trials).
Itil T; Gannon P; Cora R; Polvan N; Akpinar S; Elveris F; Eskazan E
Behav Neuropsychiatry; 1972; 4(4-5):15-24. PubMed ID: 4566673
[No Abstract] [Full Text] [Related]
16. [Trial of dipotassium chlorazepate in child psychiatry].
Launay C; Houzel D
Rev Neuropsychiatr Infant; 1972 May; 20(5):491-5. PubMed ID: 5081843
[No Abstract] [Full Text] [Related]
17. Double-blind evaluation of prazepam, chlordiazepoxide and placebo in non-psychotic patients with anxiety and tension: some methodological considerations.
Kingstone E; Villeneuve A; Kossatz I
Curr Ther Res Clin Exp; 1969 Mar; 11(3):106-14. PubMed ID: 4976238
[No Abstract] [Full Text] [Related]
18. [Clinical experimentation with lorazepam (Temesta) in ambulatory practice].
Aflalo M; Berkowitch S; Thielemans G; Vermeylen J
Acta Psychiatr Belg; 1972 Nov; 72(6):756-66. PubMed ID: 4679558
[No Abstract] [Full Text] [Related]
19. SCH 12041. A new antianxiety agent.
Gallant DM; Bishop MP
Curr Ther Res Clin Exp; 1971 Feb; 13(2):107-10. PubMed ID: 4994212
[No Abstract] [Full Text] [Related]
20. Somatosensory evoked potential: an objective indicator of the therapy efficacy of a new psychotropic drug, clorazepate dipotassium (tranxene).
Saletu B; Saletu M; Itil TM
Curr Ther Res Clin Exp; 1972 Aug; 14(8):428-41. PubMed ID: 4629305
[No Abstract] [Full Text] [Related]
[Next] [New Search]
